M&A - GAMCO INVESTORS, INC. ET AL

Form Type: SCHEDULE 13D/A

Filing Date: 2025-04-04

Corporate Action: Acquisition

Type: Update

Accession Number: 000080724925000062

Filing Summary: On April 3, 2025, the Reporting Persons, which include GAMCO Investors, Inc. and related entities, reported transactions resulting from the completed acquisition of Nevro Corp by Globus Medical, Inc. As a consequence of this acquisition, the Reporting Persons have ceased to be beneficial owners of 5% or more of Nevro Corp's common stock. The report details specific share transactions conducted on the date of acquisition, including substantial sales by various funds associated with GAMCO. The total shares sold included 62,700 shares by Gabelli & Company, 183,650 shares from Gabelli Associates Fund, and other significant transactions leading to a total of 1,573,750 shares sold, with a price of $5.85 per share across several funds. This was a significant divestiture reflecting the shift in ownership following the acquisition.

Document Link: View Document

Form Type: SCHEDULE 13D/A

Filing Date: 2025-04-03

Corporate Action: Acquisition

Type: Update

Accession Number: 000080724925000060

Filing Summary: The document is an amendment to Schedule 13D, filed by GAMCO Investors, Inc. et al., and it details the completion of the acquisition of VOXX International Corp by Gentex Corporation on April 1, 2025. Following this acquisition, the Reporting Persons, which include several investment firms and individuals associated with GAMCO, have ceased to be beneficial owners of 5% or more of the Issuer's common stock. A series of transactions executed on April 1, 2025, involved significant sells of shares across various funds, including Gabelli Funds LLC and GAMCO Asset Management Inc., totaling large quantities of common stock at a price of $7.50 per share. This amendment reflects the changes in ownership status post-acquisition and provides transaction details over the last sixty days, confirming the Reporting Persons no longer hold shares in the company post-acquisition.

Document Link: View Document

Form Type: SCHEDULE 13D/A

Filing Date: 2025-04-02

Corporate Action: Acquisition

Type: Update

Accession Number: 000080724925000058

Filing Summary: The document outlines the filing of a Schedule 13D/A on behalf of GAMCO Investors, Inc. and other reporting persons regarding their ownership in Intevac Inc. This filing indicates that the acquisition of Intevac by Seagate Technology Holdings plc has been completed. As a result of this acquisition, the reporting persons no longer hold any beneficial ownership of the shares of Intevac, having ceased to own 5% or more of its common stock as of March 31, 2025. The filing includes details of transactions executed by various funds managed by GAMCO and affiliated companies on March 31, 2025, where several shares were sold at a price of $4.00, highlighting the concluding activities related to the acquisition. The general counsel and various officers of the reporting persons are listed, confirming the actions taken on April 2, 2025.

Document Link: View Document

Form Type: SCHEDULE 13D/A

Filing Date: 2024-12-30

Corporate Action: Merger

Type: Update

Accession Number: 000080724924000198

Filing Summary: On December 30, 2024, the Gabelli Value 25 Fund, on behalf of GAMCO and its clients, filed a Verified Complaint under Delaware law to compel the inspection of books and records of Paramount Global in connection with its merger with Skydance Group. This complaint was filed under seal, and a public version is expected by January 6, 2025. The complaint alleges that Paramount failed to comply with a prior demand for information made on November 8, 2024, regarding the fairness of the Skydance merger for minority shareholders, particularly concerning NAI's controlling stake in Paramount. The Schedule 13D relates to 4,768,277 shares of Paramount, equivalent to 11.71% of its total shares outstanding, with GAMCO holding 2,511,336 shares (6.17%).

Document Link: View Document